Article Text


230 Hypophosphatemia: A Risk Factor for Insulin Requirement in Elbw Infants?
  1. L Dreyfus1,
  2. CJ Fischer1,2,
  3. D Maucort-Boulch3,4,5,
  4. M Essomo Megnier Mbo Owono1,6,
  5. S Laborie1,
  6. O Claris1,7
  1. 1Department of Neonatology, Hôpital Femme Mère Enfant Hospices Civils de Lyon, Bron, France
  2. 2Department of Neonatology, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland
  3. 3Department of Biostatistics, Hospices Civils de Lyon, Lyon
  4. 4CNRS UMR 5558. Equipe Biostatistique-Santé, Laboratoire de Biométrie et Biologie Evolutive
  5. 5Université Claude Bernard Lyon 1, Villeurbanne, France
  6. 6Department of Neonatology, Centre Hospitalier de Libreville, Libreville, Gabon
  7. 7EAM 4128, Université Claude Bernard Lyon 1, Villeurbanne, France


Background and aims Insulin is frequently required to treat hyperglycemia that increases both mortality and morbidity in ELBW infants. Adult and animal studies suggest a link between hypophosphatemia and insulin resistance. Our objective was to define whether hypophosphatemia increases the risk of insulin requirement in ELBW infants.

Methods This observational study included ELBW infants admitted in our NICU between 01.01.2010 and 31.12.2011 who survived until DOL14. Laboratory and clinical data were retrospectively collected. According to the NICU policy, phosphatemia was measured before DOL3 and glycemia was checked daily during parenteral nutrition. Insulin was introduced in case of refractory hyperglycemia >11mmol/l. Depending on the lowest phosphatemia before DOL3, patients were divided into hypophosphatemic (HP, < 1.2 mmol/l) and controls (≥1.2 mmol/l). Uni- and multivariable analysis compared the time to insulin requirement using survival models.

Results In all, 126 patients were included: 39 HP, 87 controls. Mean(SD) gestational age was 27.8 (1.5) in HP and 27.4 (1.5) weeks in controls, birthweight was 770 (140) and 837 (109) grams. Insulin was required in 19/39 (49%) HP and 26/87 (30%) controls with a delay of 17 (10) and 22 (9) days respectively. The unadjusted hazard ratio of insulin requirement in HP was 1.93 (95%CI: 1.07–3.49, p=0.03). After adjustment for gestational age, birthweight, sex, IUGR and sepsis, the hazard ratio was still 1.6 (95%CI: 0.86–3.17) but not significant (p=0.13).

Conclusion Hypophosphatemia may be a risk factor for insulin requirement in ELBW. Multivariable analysis shows that age and birthweight could also influence this outcome. Whether aggressive management of hypophosphatemia can improve glycemia control deserves to be studied.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.